These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
115 related articles for article (PubMed ID: 7761444)
1. A disaccharide that inhibits tumor necrosis factor alpha is formed from the extracellular matrix by the enzyme heparanase. Lider O; Cahalon L; Gilat D; Hershkoviz R; Siegel D; Margalit R; Shoseyov O; Cohen IR Proc Natl Acad Sci U S A; 1995 May; 92(11):5037-41. PubMed ID: 7761444 [TBL] [Abstract][Full Text] [Related]
2. Thrombin enhances degradation of heparan sulfate in the extracellular matrix by tumor cell heparanase. Benezra M; Vlodavsky I; Bar-Shavit R Exp Cell Res; 1992 Jul; 201(1):208-15. PubMed ID: 1612123 [TBL] [Abstract][Full Text] [Related]
3. Inhibition of T lymphocyte heparanase by heparin prevents T cell migration and T cell-mediated immunity. Lider O; Mekori YA; Miller T; Bar-Tana R; Vlodavsky I; Baharav E; Cohen IR; Naparstek Y Eur J Immunol; 1990 Mar; 20(3):493-9. PubMed ID: 2318247 [TBL] [Abstract][Full Text] [Related]
4. Murine macrophage heparanase: inhibition and comparison with metastatic tumor cells. Savion N; Disatnik MH; Nevo Z J Cell Physiol; 1987 Jan; 130(1):77-84. PubMed ID: 3805131 [TBL] [Abstract][Full Text] [Related]
5. Expression of heparanase by platelets and circulating cells of the immune system: possible involvement in diapedesis and extravasation. Vlodavsky I; Eldor A; Haimovitz-Friedman A; Matzner Y; Ishai-Michaeli R; Lider O; Naparstek Y; Cohen IR; Fuks Z Invasion Metastasis; 1992; 12(2):112-27. PubMed ID: 1399400 [TBL] [Abstract][Full Text] [Related]
6. Heparin disaccharides inhibit tumor necrosis factor-alpha production by macrophages and arrest immune inflammation in rodents. Cahalon L; Lider O; Schor H; Avron A; Gilat D; Hershkoviz R; Margalit R; Eshel A; Shoseyev O; Cohen IR Int Immunol; 1997 Oct; 9(10):1517-22. PubMed ID: 9352356 [TBL] [Abstract][Full Text] [Related]
7. Heparin-disaccharide affects T cells: inhibition of NF-kappaB activation, cell migration, and modulation of intracellular signaling. Hecht I; Hershkoviz R; Shivtiel S; Lapidot T; Cohen IR; Lider O; Cahalon L J Leukoc Biol; 2004 Jun; 75(6):1139-46. PubMed ID: 15020655 [TBL] [Abstract][Full Text] [Related]
8. Soluble antigen induces T lymphocytes to secrete an endoglycosidase that degrades the heparan sulfate moiety of subendothelial extracellular matrix. Fridman R; Lider O; Naparstek Y; Fuks Z; Vlodavsky I; Cohen IR J Cell Physiol; 1987 Jan; 130(1):85-92. PubMed ID: 2433294 [TBL] [Abstract][Full Text] [Related]
9. Sequential degradation of heparan sulfate in the subendothelial extracellular matrix by highly metastatic lymphoma cells. Bar-Ner M; Kramer MD; Schirrmacher V; Ishai-Michaeli R; Fuks Z; Vlodavsky I Int J Cancer; 1985 Apr; 35(4):483-91. PubMed ID: 3157649 [TBL] [Abstract][Full Text] [Related]
10. Structural requirements for inhibition of melanoma lung colonization by heparanase inhibiting species of heparin. Bitan M; Mohsen M; Levi E; Wygoda MR; Miao HQ; Lider O; Svahn CM; Ekre HP; Ishai-Michaeli R; Bar-Shavit R Isr J Med Sci; 1995; 31(2-3):106-18. PubMed ID: 7744578 [TBL] [Abstract][Full Text] [Related]
11. Involvement of both heparanase and plasminogen activator in lymphoma cell-mediated degradation of heparan sulfate in the subendothelial extracellular matrix. Bar-Ner M; Mayer M; Schirrmacher V; Vlodavsky I J Cell Physiol; 1986 Aug; 128(2):299-306. PubMed ID: 2426287 [TBL] [Abstract][Full Text] [Related]
12. Disaccharides generated from heparan sulphate or heparin modulate chemokine-induced T-cell adhesion to extracellular matrix. Hershkoviz R; Schor H; Ariel A; Hecht I; Cohen IR; Lider O; Cahalon L Immunology; 2000 Jan; 99(1):87-93. PubMed ID: 10651945 [TBL] [Abstract][Full Text] [Related]
13. A sulfated disaccharide derived from chondroitin sulfate proteoglycan protects against inflammation-associated neurodegeneration. Rolls A; Cahalon L; Bakalash S; Avidan H; Lider O; Schwartz M FASEB J; 2006 Mar; 20(3):547-9. PubMed ID: 16396993 [TBL] [Abstract][Full Text] [Related]
15. Inhibition of tumor metastasis by heparanase inhibiting species of heparin. Vlodavsky I; Mohsen M; Lider O; Svahn CM; Ekre HP; Vigoda M; Ishai-Michaeli R; Peretz T Invasion Metastasis; 1994-1995; 14(1-6):290-302. PubMed ID: 7657522 [TBL] [Abstract][Full Text] [Related]
16. Modulation of the heparanase-inhibiting activity of heparin through selective desulfation, graded N-acetylation, and glycol splitting. Naggi A; Casu B; Perez M; Torri G; Cassinelli G; Penco S; Pisano C; Giannini G; Ishai-Michaeli R; Vlodavsky I J Biol Chem; 2005 Apr; 280(13):12103-13. PubMed ID: 15647251 [TBL] [Abstract][Full Text] [Related]
17. Lung colonization by and heparanase activity in in vitro transformed 3T3 cells rendered highly tumorigenic by an in vivo passage. Katz BZ; Ishai-Michaeli R; Zusman T; Vlodavsky I; Witz IP Invasion Metastasis; 1994-1995; 14(1-6):276-89. PubMed ID: 7657521 [TBL] [Abstract][Full Text] [Related]
18. Differential effects of polysulfated polysaccharide on experimental encephalomyelitis, proliferation of autoimmune T cells, and inhibition of heparanase activity. Hershkoviz R; Mor F; Miao HQ; Vlodavsky I; Lider O J Autoimmun; 1995 Oct; 8(5):741-50. PubMed ID: 8579728 [TBL] [Abstract][Full Text] [Related]
19. Comparative analysis of the ability of leucocytes, endothelial cells and platelets to degrade the subendothelial basement membrane: evidence for cytokine dependence and detection of a novel sulfatase. Bartlett MR; Underwood PA; Parish CR Immunol Cell Biol; 1995 Apr; 73(2):113-24. PubMed ID: 7797231 [TBL] [Abstract][Full Text] [Related]
20. Role of endothelial heparanase in delayed-type hypersensitivity. Edovitsky E; Lerner I; Zcharia E; Peretz T; Vlodavsky I; Elkin M Blood; 2006 May; 107(9):3609-16. PubMed ID: 16384929 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]